Go Pro
CVE:NVH

Novoheart (NVH) Stock Price, News & Analysis

C$0.53 +0.01 (+1.92%)
As of 11/20/2020

About Novoheart Stock (CVE:NVH)

Key Stats

Today's Range
C$0.52
C$0.53
50-Day Range
C$0.53
C$0.53
52-Week Range
C$0.26
C$0.72
Volume
23,066 shs
Average Volume
33,593 shs
Market Capitalization
C$99.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Novoheart Holdings Inc. operates as a stem cell biotechnology company in the United States. The company offers an array of next-generation human heart tissue prototypes. It provides MyHeart platform products, including human pluripotent stem cell-derived cardiomyocytes, human ventricular cardiac anisotropic sheet assays, and human ventricular cardiac tissue strips assays. The company also offers screening and phenotyping services; and consultation services, including mapping and designing preclinical studies that involve human embryonic or induced pluripotent stem cell-derived cardiomyocytes, prototyping custom bioreactor designs, and developing custom software for streamlining of screening platforms and analysis of acquired data. Novoheart Holdings Inc. has a collaboration with AstraZeneca to develop human-specific in vitro functional model of heart failure with preserved ejection fraction. The company is based in Vancouver, Canada.

Receive NVH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novoheart and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NVH Stock News Headlines

Capgemini SE (CAP.PA)
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this supercycle - and says that may be conservative. Billionaire Pierre Lassonde has argued for $19,000. Former CIA advisor Jim Rickards targets $27,000 based on a federal revaluation of the gold supply. But the bigger opportunity may not be gold itself. A 'backdoor' gold-linked asset has historically multiplied gold's move by 10x or more - returning 846%, 1,668%, 1,847%, and 1,915% in the last supercycle.tc pixel
067570.KQ - NVH Korea Inc.
NVH Korea Inc (067570)
Novoheart Holdings Inc (NVH)
See More Headlines

NVH Stock Analysis - Frequently Asked Questions

Novoheart's stock was trading at C$0.53 on January 1st, 2026. Since then, NVH stock has increased by 0.0% and is now trading at C$0.53.

Shares of NVH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Novoheart investors own include Athabasca Oil (ATH), Black Iron (BKI), Berry (BRY), Castor Maritime (CTRM), IT Tech Packaging (ITP), SOS (SOS) and Sarepta Therapeutics (SRPT).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
CVE:NVH
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
27.62
Current Ratio
6.13
Quick Ratio
6.05

Sales & Book Value

Annual Sales
C$423.50 thousand
Price / Sales
236.08
Cash Flow
C$0.07 per share
Price / Cash Flow
7.46
Book Value
C$0.12 per share
Price / Book
4.34

Miscellaneous

Outstanding Shares
188,641,000
Free Float
N/A
Market Cap
C$99.98 million
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (CVE:NVH) was last updated on 9/20/2026 by MarketBeat.com Staff.
From Our Partners